What is Altimmune's earnings yield?

Altimmune (ALT) reported earnings yield of -22.7% in Q1 2026.

How has Altimmune's earnings yield changed year-over-year?

Altimmune's earnings yield increased by 3.0% year-over-year, from -23.4% to -22.7%.

What is the long-term trend for Altimmune's earnings yield?

Over 5 years (2020 to 2025), Altimmune's earnings yield has grown at a 16.4% compound annual growth rate (CAGR), from -10.9% to -23.4%.

What does earnings yield mean?

Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.

Altimmune ALT Earnings yield

Earnings yield at other companies

Eli LillyLLY

3.1%+1.6pp

Merck & Co.MRK

3%-4.7pp

Madrigal Pharmaceuticals, Inc.MDGL

-2.6%-0.9pp

Viking TherapeuticsVKTX

-12.6%-31.7pp

Wave Life SciencesWVE

-13.5%—

Delcath SystemsDCTH

0.3%+0.2pp

Other financials

Income statement

See full

Revenue$26.0K+420%

Operating income-$24.2M-11.1%

Net income-$22.6M-15.3%

EPS (diluted)-$0.18+30.8%

Balance sheet

See full

Cash & equivalents$97.6M+98.7%

Total debt$34.8M+14,092%

Total equity$284.0M+99.8%

Total assets$335.6M+113%

Cash flow

See full

Operating cash flow-$20.9M-24.4%

CapEx$21.0K—

Free cash flow-$21.0M—

Valuation

See full

Market cap$558.14M-2.1%

Enterprise value$495.27M-5.0%

P/S13,613.2×-24,380×

Profitability

See full

Operating margin-230,461%-82,087pp

Net margin-214,861%-76,057pp

FCF margin-17,806.8%-110,030pp

Returns & leverage

See full

Return on equity-42.7%-8.7pp

Debt / equity0.1×+0.1×

Current ratio29.6×+13.7×

Where this comes from

Calculated from Altimmune’s reported figures.

net income/market cap=-22.7%

Based on trailing twelve months.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Altimmune's earnings yield?: Altimmune (ALT) reported earnings yield of -22.7% in Q1 2026.
How has Altimmune's earnings yield changed year-over-year?: Altimmune's earnings yield increased by 3.0% year-over-year, from -23.4% to -22.7%.
What is the long-term trend for Altimmune's earnings yield?: Over 5 years (2020 to 2025), Altimmune's earnings yield has grown at a 16.4% compound annual growth rate (CAGR), from -10.9% to -23.4%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.